Autoimmune disorders are characterized by the immune system's failure to maintain self-tolerance, resulting in an abnormal immune response directed against the body's own cells and organs.
 

• Loss of Central and Peripheral Tolerance: Normally, self-reactive T and B cells are eliminated during maturation (central tolerance) or suppressed in the periphery (peripheral tolerance). In autoimmune conditions, genetic susceptibility interacts with environmental triggers to bypass this.

• Tissue Destruction Mechanisms:

  • Type II Hypersensitivity: Autoantibodies bind to cell-surface antigens, triggering complement activation, phagocytosis, or antibody-dependent cellular cytotoxicity (e.g., Graves' disease, autoimmune hemolytic anemia).

  • Type III Hypersensitivity: Circulating immune complexes deposit in microvasculature and tissues, inciting localized inflammation and neutrophil recruitment (e.g., systemic lupus erythematosus).

  • Type IV Hypersensitivity: Cell-mediated destruction driven by autoreactive T-cells releasing inflammatory cytokines and activating macrophages (e.g., type 1 diabetes, rheumatoid arthritis, multiple sclerosis).

​

Organ-Specific Autoimmune Diseases
 

• Endocrine System:

  • Hashimoto's Thyroiditis: Autoantibody-mediated destruction of the thyroid gland, leading to primary hypothyroidism.

  • Graves' Disease: Stimulating autoantibodies against the TSH receptor, leading to hyperthyroidism.

  • Type 1 Diabetes Mellitus: T-cell-mediated autoimmune destruction of insulin-producing pancreatic beta cells.

• Gastrointestinal / Dermatologic / Neurologic:

  • Celiac Disease: Immune reaction to dietary gluten mediated by tissue transglutaminase antibodies, causing small intestinal villous atrophy.

  • Psoriasis: Immune-mediated hyperproliferation of keratinocytes driven by T-cell signaling.

  • Multiple Sclerosis (MS): Autoimmune demyelination of the central nervous system driven by autoreactive T-cells targeting myelin sheath proteins, leading to axonal damage and neurologic deficits.

Systemic & Inflammatory Rheumatic Diseases
 

• Systemic Lupus Erythematosus (SLE): Multisystem inflammatory disease characterized by autoantibody production (e.g., ANA, anti-dsDNA) affecting skin, joints, kidneys, and serosal membranes.

• Rheumatoid Arthritis (RA): Chronic, symmetric inflammatory polyarthritis primarily targeting synovial membranes, driven by rheumatoid factor (RF) and anti-cyclic citrullinated peptide (anti-CCP) antibodies.

• Psoriatic Arthritis (PsA): Chronic systemic inflammatory arthritis associated with cutaneous psoriasis. Driven by T-cells and pro-inflammatory cytokines (TNF-alpha, IL-17, IL-23) targeting peripheral joints, axial skeleton, and entheses.

• Polymyalgia Rheumatica (PMR): Inflammatory rheumatic condition occurring almost exclusively in adults aged 50+ (peak age 70–80). Core pathology is synovitis and bursitis of the shoulder and hip girdles driven by elevated IL-6. (Closely linked to Giant Cell Arteritis).

• Sjögren's Syndrome: Exocrine gland destruction (lacrimal and salivary glands) causing severe dry eyes (keratoconjunctivitis sicca) and dry mouth (xerostomia).

• Scleroderma (Systemic Sclerosis): Autoimmune vasculopathy and excessive fibrosis of the skin and internal organs.

Clinical Presentation & Common Symptoms
 

Hashimoto's Thyroiditis

• Fatigue and sluggishness

• Unexplained weight gain or difficulty losing weight

• Cold intolerance (feeling cold when others do not)

• Dry skin, coarse hair, and hair thinning

• Constipation

• Bradycardia (slow heart rate)

Graves' Disease

• Heat intolerance and excessive sweating

• Unintentional weight loss despite an increased appetite

• Palpitations, tachycardia (fast heart rate), and tremors

• Anxiety, irritability, and nervousness

• Exophthalmos (bulging eyes) and lid lag

• Frequent bowel movements or diarrhea

Type 1 Diabetes Mellitus

• Polyuria (excessive urination)

• Polydipsia (excessive thirst)

• Polyphagia (increased hunger)

• Unintentional and rapid weight loss

• Severe fatigue, weakness, and lethargy

• Blurry vision

Celiac Disease

• Chronic diarrhea or steatorrhea (fatty, foul-smelling stools)

• Abdominal pain, bloating, and gas

• Unexplained iron-deficiency anemia

• Weight loss or failure to thrive (in children)

• Dermatitis herpetiformis (an intensely itchy, blistering skin rash)

• Fatigue and brain fog

Psoriasis

• Raised, inflamed red patches of skin covered with silvery-white scales (plaques)

• Dry, cracked skin that may bleed or itch intensely

• Burning, soreness, or localized pain around plaques

• Thickened, pitted, or discolored nails

Multiple Sclerosis (MS)

• Paresthesias (numbness, tingling, or "pins and needles" sensations in the limbs)

• Muscle weakness and spasticity

• Lhermitte's sign (an electric-shock sensation down the spine upon bending the neck)

• Optic neuritis (blurred vision, pain with eye movement, or temporary loss of vision in one eye)

• Fatigue and cognitive "brain fog"

• Balance issues, dizziness, and coordination difficulties (ataxia)

Systemic Lupus Erythematosus (SLE)

• Chronic, severe fatigue and low-grade fevers

• Photosensitive malar "butterfly" rash across the cheeks and bridge of the nose

• Symmetric joint pain and stiffness (arthralgias/arthritis)

• Raynaud's phenomenon (fingers turning white/blue in response to cold)

• Pleuritic chest pain or shortness of breath (serositis)

• Unexplained proteinuria, edema, or hair loss (alopecia)

Rheumatoid Arthritis (RA)

• Symmetric pain, swelling, and tenderness in small joints (hands, wrists, feet) and neck, usually sparing the distal DIP joint/knuckle

• Prolonged morning stiffness/swelling lasting longer than 60 minutes

• Joint deformities (swan-neck, boutonnière deformities, ulnar deviation)

• Rheumatoid nodules (firm lumps of tissue under the skin over bony prominences)

• Low-grade fevers, fatigue, and malaise

Psoriatic Arthritis (PsA)

• Joint pain, stiffness, and swelling in an asymmetric or symmetric pattern

• Dactylitis ("sausage digits")—diffuse swelling of an entire finger or toe

• Enthesitis—pain and tenderness where tendons or ligaments attach to bone (e.g., Achilles tendon or heel)

• Pitting, ridging, or separation of the nails from the nail bed (onycholysis)

• Hand, feet, and back stiffness in the morning lasting longer than 30-60 minutes

Polymyalgia Rheumatica (PMR)

• Bilateral aching and stiffness in the shoulders, neck, and pelvic/hip girdle

• Marked morning stiffness lasting longer than 45 minutes, severely limiting basic movements like dressing or grooming

• Constitutional symptoms including low-grade fever, fatigue, and unintentional weight loss

• Associated symptoms of concurrent Giant Cell Arteritis (if present), such as new temporal headaches, scalp tenderness, jaw pain while chewing, or visual changes

Sjögren's Syndrome

• Keratoconjunctivitis sicca (severe dry eyes, feeling of sand or grit in the eyes)

• Xerostomia (dry mouth, difficulty swallowing or speaking, and increased dental decay)

• Swollen salivary glands (enlarged parotid glands)

• Vaginal dryness and persistent dry cough

• Severe fatigue and joint pain

Scleroderma (Systemic Sclerosis)

• Raynaud's phenomenon (often the earliest warning sign)

• Tightening, thickening, and hardening of the skin on the fingers, hands, and face

• Sclerodactyly (stiff, tapering fingers with restricted range of motion)

• Dysphagia (difficulty swallowing) and acid reflux due to esophageal dysmotility

• Shortness of breath or dry cough from pulmonary fibrosis

• Constitutional "Red Flag" Symptoms: Persistent fatigue, low-grade fevers, unintentional weight loss, and generalized malaise, reflecting systemic cytokine release.

• Musculoskeletal & Articular Manifestations: Symmetric polyarthralgia, joint swelling, morning stiffness lasting greater than 30 to 60 minutes (or > 45 minutes for PMR), dactylitis ("sausage digits") and enthesitis in PsA, and proximal girdle stiffness in PMR.

• Neurologic & Visual Manifestations: Focal neurologic deficits, optic neuritis, paresthesias, or cognitive fatigue in MS; GCA red flags (temporal headaches, scalp tenderness, jaw claudication, visual changes) in PMR overlaps.

• Dermatologic Manifestations: Photosensitive rashes (e.g., malar "butterfly" rash in SLE), oral ulcers, Raynaud's phenomenon (vasospasm of digits in response to cold or stress), psoriatic skin plaques, nail pitting, and alopecia.

• Organ-Specific Symptoms: Ranging from nephritis, cytopenias, and serositis to gastrointestinal malabsorption or endocrinopathies depending on the targeted tissue.

Diagnostics
 

• Laboratory Testing:

  • Inflammatory Markers: Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) to detect systemic inflammation (markedly elevated in PMR, RA, and PsA flares).

  • Autoantibody Panels:

    • Antinuclear Antibodies (ANA): Highly sensitive screening test for systemic autoimmune rheumatic diseases, particularly SLE.

    • Disease-Specific Serologies: Anti-dsDNA and Anti-Sm (for SLE), Anti-CCP and RF (for RA), Anti-TPO (for Hashimoto's), Anti-SSA/Ro and Anti-SSB/La (for Sjögren's). Note: RF and Anti-CCP are typically negative in PsA and PMR.

  • Organ Function Panels: Complete blood counts, comprehensive metabolic panels, urinalysis (to check for protein/hematuria in lupus nephritis), and thyroid panels.

• Imaging and Biopsy:

  • Radiographs & Advanced Imaging: Plain films for erosive changes (RA) or periostitis/sacroiliitis (PsA); MRI of the brain and spinal cord demonstrating dissemination in space and time for Multiple Sclerosis; specialized ultrasound or MRI for joint synovitis and bursitis.

  • Tissue Biopsies & Lumbar Puncture: Skin, kidney, or minor salivary gland biopsies; cerebrospinal fluid (CSF) analysis showing oligoclonal bands for MS confirmation.

Management

Pharmacotherapy (Immunomodulation & Immunosuppression)

• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Used for symptomatic pain, acute musculoskeletal inflammation, or mild joint/enthesitis flares.

• Corticosteroids: Rapid-acting anti-inflammatory agents utilized for acute flares, MS relapses, or low-dose management in PMR (typically 15 to 20 mg daily, with mandatory concurrent bone protection: calcium, vitamin D, and bisphosphonates).

• Conventional Disease-Modifying Anti-Rheumatic Drugs (cDMARDs): Slow-acting agents that modulate immune function to halt disease progression (e.g., methotrexate for RA and PsA, hydroxychloroquine for SLE, leflunomide, sulfasalazine).

• Disease-Modifying Therapies for Multiple Sclerosis (DMTs): High-efficacy immunomodulatory and immunosuppressive agents (e.g., high-efficacy monoclonal antibodies, B-cell depleting therapies) to suppress central nervous system demyelination and reduce relapse rates.

• Biologic DMARDs & Targeted Synthetic DMARDs: Precision therapies targeting specific inflammatory cytokines or pathways (e.g., TNF inhibitors, IL-17 inhibitors, IL-12/23 inhibitors, IL-6 inhibitors, and JAK inhibitors for rheumatic conditions).

Lifestyle & Supportive Care

• Trigger Avoidance: Identifying and minimizing flares triggered by sun exposure (ultraviolet light in SLE), infections, tobacco use, or specific dietary allergens (e.g., gluten in celiac disease).

• Cardiovascular and Bone Health: Managing secondary risks such as premature atherosclerosis and corticosteroid-induced osteoporosis through lifestyle modifications, calcium/vitamin D supplementation, and bone-density monitoring.